Head-to-head · WeighScore
Auren Rx vs NuBloom
The verdict
Auren Rx takes it — 72.9/100 to 69/100.
Auren Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Auren Rx charges the same $149 for semaglutide and tirzepatide, which removes the usual reason to start on the weaker molecule.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Auren Rx | NuBloom |
|---|---|---|
| WeighScore | 72.9/100 | 69/100 |
| Grade | C | C |
| Site position | #83 | #151 |
| Semaglutide | $149/mo (auto-refill; a single month with no commitment is $179) | $149/mo (2.4 mg dose, compounded) |
| Tirzepatide | $149/mo (auto-refill; a single month with no commitment is $179) | $279/mo (15 mg dose, compounded) |
| Coverage | All 50 states | 49 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #83 · C
Strengths
- Semaglutide and tirzepatide cost the same, so the choice of molecule is clinical rather than budgetary
- A microdose lane is priced separately at $129 on auto-refill rather than folded into the standard figure
- Names its dispensing pharmacy, VialsRX, with a street address and a phone number in Houston, Texas
- Names a prescribing physician and practice, and publishes support hours of Monday to Friday, 9 AM to 6 PM Eastern
Where it loses points
- The $149 figure requires enrolling in auto-refill; a single month with no commitment is $179
- Two different medical groups are named for the same service — Wasef Health, PC on the contact page and FAQ, Beluga Health, P.A. in the telehealth consent
- Product pages advertise a free online visit while the Terms make the initial online visit and any laboratory testing the patient's responsibility
- The FAQ says all 50 states, the Terms say service is available only in certain states, and no list is published
- No compounding class is stated for VialsRX, so whether it operates under 503A or 503B is unknown
- NAD+ is priced at two different figures on the same site, which is not reassuring about the GLP-1 numbers
Site position #151 · C
Strengths
- Transparent, openly published pricing: compounded semaglutide $149/mo and tirzepatide $279/mo as flexible month-to-month subscriptions
- Founded and medically led by a named physician (Dr. Marianne Pinkston Mueller, family/integrative medicine, 25+ years)
- Whole-person model pairs GLP-1s with hormone, gut-health and longevity care plus in-depth lab testing
- State coverage published openly: 49 states listed on the site (all except Mississippi)
- Optional 90-day 1:1 coaching program with weekly meetings and unlimited text support ($599/mo)
Where it loses points
- Compounding pharmacy partners are not named anywhere on the site — a transparency gap
- NuBloom's own LegitScript/PCAB status is not displayed; only its telehealth partner is certified
- Compounded medications are not FDA-approved; one FAQ loosely calls them 'FDA-approved,' contradicting the product pages
- All sales are final and medical consult fees are non-refundable; no returns on prescription products
- Disputes go to binding individual arbitration; the Terms' governing-law state is left as an unfilled '[STATE]' placeholder
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.